{"entity":{"type":"insider","cik":"0001425394","url":"/insider/0001425394","json_url":"/insider/0001425394.json","name":"Sohail Faysal A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":8,"first":"2013-03-27","last":"2018-07-26","span_basis":"filed_date"},"name_variants":[{"name":"Sohail Faysal A.","source":"filing","n_filings":8,"first_seen":"2013-03-27","last_seen":"2018-07-26"}],"transactions":[{"id":6749567,"accession":"0001144204-18-040247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-18-040247","line_url":"/filing/0001144204-18-040247","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Menlo Therapeutics Inc.","issuer_ticker":"MNLO","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Watson James F; Presidio Partners 2007 (Parallel), L.P.; Sohail Faysal A.; Collier David J; Presidio Partners 2007 GP, L.P.; Presidio Partners 2007, L.P.","owner_display_name":"Watson James F","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":3825000.0,"total_display":"3,825,000.00","total_whole":"3,825,000","shares_owned_after":1907568.0,"shares_owned_after_display":"1,907,568","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2018-07-26","scope":"insider","n_lines":2},{"id":2248030,"accession":"0001209191-16-115074","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_display_name":"Presidio Partners 2007 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8540.0,"shares_display":"8,540","price_per_share":9.8841,"price_display":"9.88","price_state":"stated","total_value":84410.214,"total_display":"84,410.21","total_whole":"84,410","shares_owned_after":1559995.0,"shares_owned_after_display":"1,559,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-20","scope":"insider","n_lines":2},{"id":2248020,"accession":"0001209191-16-115074","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_display_name":"Presidio Partners 2007 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7279.0,"shares_display":"7,279","price_per_share":10.029,"price_display":"10.03","price_state":"stated","total_value":73001.091,"total_display":"73,001.09","total_whole":"73,001","shares_owned_after":1568322.0,"shares_owned_after_display":"1,568,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-20","scope":"insider","n_lines":2},{"id":2248009,"accession":"0001209191-16-115074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_display_name":"Presidio Partners 2007 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4548.0,"shares_display":"4,548","price_per_share":10.0996,"price_display":"10.10","price_state":"stated","total_value":45932.9808,"total_display":"45,932.98","total_whole":"45,933","shares_owned_after":1575419.0,"shares_owned_after_display":"1,575,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-20","scope":"insider","n_lines":2},{"id":3352690,"accession":"0001209191-16-114436","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_display_name":"Presidio Partners 2007 (Parallel), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18210.0,"shares_display":"18,210","price_per_share":10.201453871499176,"price_display":"10.20","price_state":"stated","total_value":185768.475,"total_display":"185,768.48","total_whole":"185,768","shares_owned_after":1586873.0,"shares_owned_after_display":"1,586,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-15","scope":"insider","n_lines":4},{"id":3352682,"accession":"0001209191-16-114436","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_display_name":"Presidio Partners 2007 (Parallel), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27066.0,"shares_display":"27,066","price_per_share":10.291331892411144,"price_display":"10.29","price_state":"stated","total_value":278545.189,"total_display":"278,545.19","total_whole":"278,545","shares_owned_after":1610283.0,"shares_owned_after_display":"1,610,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-15","scope":"insider","n_lines":4},{"id":3352670,"accession":"0001209191-16-114436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_display_name":"Presidio Partners 2007 (Parallel), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12692.0,"shares_display":"12,692","price_per_share":10.1619,"price_display":"10.16","price_state":"stated","total_value":128974.8348,"total_display":"128,974.83","total_whole":"128,975","shares_owned_after":1623997.0,"shares_owned_after_display":"1,623,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-13","filed_date":"2016-04-15","scope":"insider","n_lines":2},{"id":6680089,"accession":"0001209191-14-068129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-068129","line_url":"/filing/0001209191-14-068129","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Collier David J; Sohail Faysal A.; CMEA Ventures VI Management, L.P.; CMEA Ventures VI GmbH & Co. KG; CMEA VENTURES VI LP; Watson James F","owner_display_name":"Collier David J","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4481255.0,"shares_display":"4,481,255","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":9858761.0,"total_display":"9,858,761.00","total_whole":"9,858,761","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-12","scope":"insider","n_lines":2},{"id":6360774,"accession":"0001012975-14-000433","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-21","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":2.8636,"price_display":"2.86","price_state":"stated","total_value":5154.48,"total_display":"5,154.48","total_whole":"5,154","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-06-25","scope":"insider"},{"id":6360771,"accession":"0001012975-14-000433","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-20","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":2.8336,"price_display":"2.83","price_state":"stated","total_value":5100.48,"total_display":"5,100.48","total_whole":"5,100","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-06-25","scope":"insider"},{"id":6360768,"accession":"0001012975-14-000433","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-19","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":711.0,"shares_display":"711","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":1955.25,"total_display":"1,955.25","total_whole":"1,955","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-06-25","scope":"insider"},{"id":6360765,"accession":"0001012975-14-000433","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-18","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":2.7475,"price_display":"2.75","price_state":"stated","total_value":3409.6475,"total_display":"3,409.65","total_whole":"3,410","shares_owned_after":4600.0,"shares_owned_after_display":"4,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-17","filed_date":"2014-06-25","scope":"insider"},{"id":6360762,"accession":"0001012975-14-000433","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2558.0,"shares_display":"2,558","price_per_share":2.754237959343237,"price_display":"2.75","price_state":"stated","total_value":7045.3407,"total_display":"7,045.34","total_whole":"7,045","shares_owned_after":711.0,"shares_owned_after_display":"711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-14","filed_date":"2014-06-25","scope":"insider","n_lines":2},{"id":6360758,"accession":"0001012975-14-000433","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-15","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1528.0,"shares_display":"1,528","price_per_share":2.7179,"price_display":"2.72","price_state":"stated","total_value":4152.9512,"total_display":"4,152.95","total_whole":"4,153","shares_owned_after":2018.0,"shares_owned_after_display":"2,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-13","filed_date":"2014-06-25","scope":"insider"},{"id":4808177,"accession":"0001012975-13-000448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-13-000448","line_url":"/filing/0001012975-13-000448","is_derivative":false,"issuer_cik":"0001005563","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001005563","owner_cik":null,"owner_name":"CMEA Ventures VI Management, L.P.; BARUCH THOMAS R; CMEA Ventures VI GmbH & Co. KG; CMEA VENTURES VI LP; Watson James F; Collier David J; Sohail Faysal A.","owner_display_name":"CMEA Ventures VI Management, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":1020000.0,"total_display":"1,020,000.00","total_whole":"1,020,000","shares_owned_after":2007246.0,"shares_owned_after_display":"2,007,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-18","filed_date":"2013-09-20","scope":"insider","n_lines":2},{"id":5209529,"accession":"0001012975-13-000443","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-13-000443","line_url":"/filing/0001012975-13-000443","is_derivative":false,"issuer_cik":"0001005563","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001005563","owner_cik":null,"owner_name":"CMEA VENTURES VI LP; Sohail Faysal A.; CMEA Ventures VI Management, L.P.; Collier David J; BARUCH THOMAS R; CMEA Ventures VI GmbH & Co. KG; Watson James F","owner_display_name":"CMEA VENTURES VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8204.0,"shares_display":"8,204","price_per_share":9.48,"price_display":"9.48","price_state":"stated","total_value":77773.92,"total_display":"77,773.92","total_whole":"77,774","shares_owned_after":2104911.0,"shares_owned_after_display":"2,104,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-17","filed_date":"2013-09-18","scope":"insider","n_lines":2},{"id":5209524,"accession":"0001012975-13-000443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-13-000443","line_url":"/filing/0001012975-13-000443","is_derivative":false,"issuer_cik":"0001005563","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001005563","owner_cik":null,"owner_name":"CMEA VENTURES VI LP; Sohail Faysal A.; CMEA Ventures VI Management, L.P.; Collier David J; BARUCH THOMAS R; CMEA Ventures VI GmbH & Co. KG; Watson James F","owner_display_name":"CMEA VENTURES VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45264.0,"shares_display":"45,264","price_per_share":9.22,"price_display":"9.22","price_state":"stated","total_value":417334.08,"total_display":"417,334.08","total_whole":"417,334","shares_owned_after":2112923.0,"shares_owned_after_display":"2,112,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-09-18","scope":"insider","n_lines":2},{"id":6360747,"accession":"0001012975-14-000433","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-11","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3546.0,"shares_display":"3,546","price_per_share":5.6131,"price_display":"5.61","price_state":"stated","total_value":19904.0526,"total_display":"19,904.05","total_whole":"19,904","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-12","filed_date":"2014-06-25","scope":"insider"},{"id":6360736,"accession":"0001012975-14-000433","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-7","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.3375,"price_display":"7.34","price_state":"stated","total_value":2935.0,"total_display":"2,935.00","total_whole":"2,935","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-09","filed_date":"2014-06-25","scope":"insider"},{"id":6360732,"accession":"0001012975-14-000433","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433#line-6","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3146.0,"shares_display":"3,146","price_per_share":7.4227,"price_display":"7.42","price_state":"stated","total_value":23351.8142,"total_display":"23,351.81","total_whole":"23,352","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-05","filed_date":"2014-06-25","scope":"insider"},{"id":6360729,"accession":"0001012975-14-000433","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001012975-14-000433","line_url":"/filing/0001012975-14-000433","is_derivative":false,"issuer_cik":"0001266748","issuer_name":"INTERMOLECULAR INC","issuer_ticker":"IMI","issuer_name_source":null,"issuer_url":"/issuer/0001266748","owner_cik":null,"owner_name":"Sohail Faysal A.; Collier David J; Watson James F; CMEA VENTURES VI LP; CMEA Ventures VI GmbH & Co. KG; CMEA Ventures VI Management, L.P.","owner_display_name":"Sohail Faysal A.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7092.0,"shares_display":"7,092","price_per_share":7.26665,"price_display":"7.27","price_state":"stated","total_value":51535.0818,"total_display":"51,535.08","total_whole":"51,535","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2014-06-25","scope":"insider","n_lines":2},{"id":4824462,"accession":"0001181431-13-019231","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-13-019231","line_url":"/filing/0001181431-13-019231","is_derivative":false,"issuer_cik":"0001005563","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001005563","owner_cik":null,"owner_name":"CMEA VENTURES VI LP; Sohail Faysal A.; CMEA Ventures VI GmbH & Co. KG; Collier David J; Handelsman Karl D.; BARUCH THOMAS R; Watson James F; CMEA Ventures VI Management, L.P.","owner_display_name":"CMEA VENTURES VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":642857.0,"shares_display":"642,857","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":4499999.0,"total_display":"4,499,999.00","total_whole":"4,499,999","shares_owned_after":2157130.0,"shares_owned_after_display":"2,157,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-03-27","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001566044","name":"Menlo Therapeutics Inc.","url":"/issuer/0001566044","role":"Other","n_filings":1,"first_seen":"2018-07-26","last_seen":"2018-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001467652","name":"Neos Therapeutics, Inc.","url":"/issuer/0001467652","role":"Ten percent owner","n_filings":2,"first_seen":"2016-04-15","last_seen":"2016-04-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001311241","name":"INTERMOLECULAR INC","url":"/issuer/0001311241","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2014-06-25","last_seen":"2014-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Ten percent owner","n_filings":3,"first_seen":"2013-03-27","last_seen":"2013-09-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001425394","retrieved_at":"2026-08-23T14:15:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}